These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11282778)

  • 1. Absorption, distribution, metabolism, and excretion of a respirable antisense oligonucleotide for asthma.
    Ali S; Leonard SA; Kukoly CA; Metzger WJ; Wooles WR; McGinty JF; Tanaka M; Sandrasagra A; Nyce JW
    Am J Respir Crit Care Med; 2001 Mar; 163(4):989-93. PubMed ID: 11282778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and development of respirable antisense therapeutics for asthma.
    Sandrasagra A; Leonard SA; Tang L; Teng K; Li Y; Ball HA; Mannion JC; Nyce JW
    Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):177-81. PubMed ID: 12162700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respirable antisense oligonucleotides: a new drug class for respiratory disease.
    Tanaka M; Nyce JW
    Respir Res; 2001; 2(1):5-9. PubMed ID: 11686859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASONs: a novel antisense oligonucleotide therapeutic approach for asthma.
    Sandrasagra A; Tang L; Leonard SA; Teng K; Li Y; Mannion JC; Nyce JW
    Expert Opin Biol Ther; 2001 Nov; 1(6):979-83. PubMed ID: 11728229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology evaluation: EPI-2010, EpiGenesis.
    Zhang Z
    Curr Opin Mol Ther; 2002 Jun; 4(3):275-80. PubMed ID: 12139314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma.
    Ball HA; Sandrasagra A; Tang L; Van Scott M; Wild J; Nyce JW
    Am J Pharmacogenomics; 2003; 3(2):97-106. PubMed ID: 12749727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respirable antisense oligonucleotide (RASON) therapy for allergic asthma.
    Metzger WJ; Nyce JW
    BioDrugs; 1999 Oct; 12(4):237-43. PubMed ID: 18031178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respirable antisense oligonucleotides: a new, third drug class targeting respiratory disease.
    Nyce J
    Curr Opin Allergy Clin Immunol; 2002 Dec; 2(6):533-6. PubMed ID: 14752337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
    Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA
    Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary absorption and disposition of [14C]thiophene in rats following nose-only inhalation exposure.
    Nomeir AA; Markham PM; Chadwick M
    J Toxicol Environ Health; 1993 Jun; 39(2):223-36. PubMed ID: 8501766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation.
    Aswania O; Chrystyn H
    Biopharm Drug Dispos; 2002 May; 23(4):159-63. PubMed ID: 12015790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates.
    Guimond A; Viau E; Aubé P; Renzi PM; Paquet L; Ferrari N
    Pulm Pharmacol Ther; 2008 Dec; 21(6):845-54. PubMed ID: 18761414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats.
    Zhang R; Lu Z; Zhang X; Zhao H; Diasio RB; Liu T; Jiang Z; Agrawal S
    Clin Chem; 1995 Jun; 41(6 Pt 1):836-43. PubMed ID: 7768001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure in mice, rats and dogs.
    Turowska A; Librizzi D; Baumgartl N; Kuhlmann J; Dicke T; Merkel O; Homburg U; Höffken H; Renz H; Garn H
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):365-72. PubMed ID: 23820074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local and systemic tolerability of a 2'O-methoxyethyl antisense oligonucleotide targeting interleukin-4 receptor-α delivery by inhalation in mouse and monkey.
    Fey RA; Templin MV; McDonald JD; Yu RZ; Hutt JA; Gigliotti AP; Henry SP; Reed MD
    Inhal Toxicol; 2014 Jul; 26(8):452-63. PubMed ID: 24932560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice.
    Duan W; Chan JH; McKay K; Crosby JR; Choo HH; Leung BP; Karras JG; Wong WS
    Am J Respir Crit Care Med; 2005 Mar; 171(6):571-8. PubMed ID: 15557129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion.
    Aswania OA; Corlett SA; Chrystyn H
    Eur J Clin Pharmacol; 1998 Aug; 54(6):475-8. PubMed ID: 9776438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low.
    Kreyling WG; Semmler M; Erbe F; Mayer P; Takenaka S; Schulz H; Oberdörster G; Ziesenis A
    J Toxicol Environ Health A; 2002 Oct; 65(20):1513-30. PubMed ID: 12396866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.